Some studies reported that therapeutic administration of anti-CD3, anti-IL-17, anti-IL-25 antibodies and proinsulin DNA improved hyperglycemia in diabetic NOD mice [43]–[47]. The gene discussed is IL17A; the disease is Hyperglycemia.